Francis M Cuss - Net Worth and Insider Trading
Francis M Cuss Net Worth
The estimated net worth of Francis M Cuss is at least $14 Million dollars as of 2024-03-28. Francis M Cuss is the EVP & CSO of Bristol-Myers Squibb Co and owns about 266,033 shares of Bristol-Myers Squibb Co (BMY) stock worth over $14 Million. Francis M Cuss is also the Director of Rubius Therapeutics Inc and owns about 10,000 shares of Rubius Therapeutics Inc (RUBY) stock worth over $570. Details can be seen in Francis M Cuss's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Francis M Cuss has not made any transactions after 2018-07-20 and currently still holds the listed stock(s).
Transaction Summary of Francis M Cuss
Francis M Cuss Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Francis M Cuss owns 2 companies in total, including Rubius Therapeutics Inc () , and Bristol-Myers Squibb Co () .
Click here to see the complete history of Francis M Cuss’s form 4 insider trades.
Insider Ownership Summary of Francis M Cuss
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
Rubius Therapeutics Inc | 2018-07-20 | director | |
Bristol-Myers Squibb Co | 2015-03-16 | EVP & CSO |
Francis M Cuss Latest Holdings Summary
Francis M Cuss currently owns a total of 2 stocks. Among these stocks, Francis M Cuss owns 266,033 shares of Bristol-Myers Squibb Co (BMY) as of March 16, 2015, with a value of $14 Million and a weighting of 100%. Francis M Cuss also owns 10,000 shares of Rubius Therapeutics Inc (RUBY) as of July 20, 2018, with a value of $570 and a weighting of 0%.
Latest Holdings of Francis M Cuss
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BMY | Bristol-Myers Squibb Co | 2015-03-16 | 266,033 | 54.17 | 14,409,677 |
RUBY | Rubius Therapeutics Inc | 2018-07-20 | 10,000 | 0.06 | 570 |
Holding Weightings of Francis M Cuss
Francis M Cuss Form 4 Trading Tracker
According to the SEC Form 4 filings, Francis M Cuss has made a total of 0 transactions in Bristol-Myers Squibb Co (BMY) over the past 5 years. The most-recent trade in Bristol-Myers Squibb Co is the sale of 114,666 shares on March 16, 2015, which brought Francis M Cuss around $8 Million.
According to the SEC Form 4 filings, Francis M Cuss has made a total of 0 transactions in Rubius Therapeutics Inc (RUBY) over the past 5 years. The most-recent trade in Rubius Therapeutics Inc is the acquisition of 10,000 shares on July 20, 2018, which cost Francis M Cuss around $230,000.
Insider Trading History of Francis M Cuss
- 1
Francis M Cuss Trading Performance
GuruFocus tracks the stock performance after each of Francis M Cuss's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Francis M Cuss is -35.46%. GuruFocus also compares Francis M Cuss's trading performance to market benchmark return within the same time period. The performance of stocks bought by Francis M Cuss within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Francis M Cuss's insider trading performs compared to the benchmark.
Performance of Francis M Cuss
Average Relative Return
Outperforming Transactions
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Relative Return(%) | -14.58 | -35.46 | -47.36 | -43.18 | -51.83 | -5.24 |
Relative Return to S&P 500(%) | -16.55 | -34.24 | -42.68 | -49.42 | -59.55 | -20.78 |
Francis M Cuss Ownership Network
Ownership Network List of Francis M Cuss
Ownership Network Relation of Francis M Cuss
Francis M Cuss Owned Company Details
What does Rubius Therapeutics Inc do?
Who are the key executives at Rubius Therapeutics Inc?
Francis M Cuss is the director of Rubius Therapeutics Inc. Other key executives at Rubius Therapeutics Inc include CEO and President Dannielle Appelhans , director & Chief Executive Officer Pablo J Cagnoni , and Chief Scientific Officer Laurence A. Turka .
Rubius Therapeutics Inc () Insider Trades Summary
Over the past 18 months, Francis M Cuss made no insider transaction in Rubius Therapeutics Inc (). Other recent insider transactions involving Rubius Therapeutics Inc () include a net sale of 15,688 shares made by Pablo J Cagnoni , a net sale of 14,263 shares made by Dannielle Appelhans , and a net sale of 2,593 shares made by Laurence A. Turka .
In summary, during the past 3 months, insiders sold 0 shares of Rubius Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 32,544 shares of Rubius Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 32,544 shares.
Rubius Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Rubius Therapeutics Inc Insider Transactions
Francis M Cuss Mailing Address
Above is the net worth, insider trading, and ownership report for Francis M Cuss. You might contact Francis M Cuss via mailing address: Bristol-myers Squibb Company, Route 206 & Province Line Road, Princeton Nj 08543.